首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1542444

全球細胞訊號市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Cell Signaling Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球細胞訊號市場需求預計將從 2023 年的 58.4 億美元達到近 117.6 億美元的市場規模，2024-2032 年研究期間複合年成長率為 8.08%。

細胞訊號傳導是一個複雜而重要的生物過程，細胞透過這個過程相互溝通以調節各種生理功能並維持體內平衡。這個複雜的系統涉及透過訊號分子（例如激素、神經傳導物質和細胞激素）將訊號從一個細胞傳輸到另一個細胞。這些分子與目標細胞表面或其內部的特定受體結合，引發一系列細胞內事件，最終導致細胞反應。此過程可大致分為幾種類型，包括自分泌、旁分泌、內分泌和鄰分泌訊號傳導，每種類型的特徵都是訊號傳播的距離及其對目標細胞的影響。有效的細胞訊號傳導對於許多生物過程至關重要，包括生長、免疫反應和組織修復。訊號通路的破壞通常與各種疾病有關，這凸顯了理解和操縱這些路徑對於治療介入的重要性。

市場動態

由於慢性病和癌症的盛行率不斷增加，細胞訊號傳導市場正在經歷強勁成長，這凸顯了對先進治療策略和診斷工具的需求。隨著研究人員深入研究這些疾病的分子機制，對複雜的細胞訊號檢測和試劑的需求激增。此外，生物技術和基因組學的快速發展促進了這些訊號技術的發展，為市場擴張提供了新的機會。高通量篩選方法和個人化醫療的整合透過實現更精確和客製化的治療方法進一步推動市場成長。此外，製藥和生技公司不斷增加的研發投資正在推動創新並加速新產品的開發。人們日益認知到細胞通訊在疾病進展和治療中的重要性也有助於市場的擴展。此外，學術機構和產業參與者之間的策略合作可以促進創新並推動市場機會。然而，與先進細胞訊號技術相關的監管複雜性和高成本可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球細胞訊號傳導市場的每個細分市場進行了包容性評估。細胞訊號傳導產業的成長和趨勢為本研究提供了整體方法。

市場區隔

細胞訊號市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按類型

內分泌訊號傳導
旁分泌訊號傳導
自分泌訊號
其他

按產品分類

耗材
儀器儀表

依技術

流式細胞儀
顯微鏡檢查
蛋白質印跡法
酵素連結免疫吸附試驗
其他

透過途徑

AKT 訊號通路
Ampk 訊號通路
ErbB/HER 訊息通路
其他訊號通路

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲細胞訊號市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。細胞訊號市場的主要參與者包括 Thermo Fisher Scientific Inc.、Qiagen、Becton、Dickinson And Company、Bio-Rad Laboratories Inc.、Bio-Techne Corporation、Cell Signaling Technology Inc.、Danaher、Merck KGaA、PerkinElmer Inc.、普洛麥格公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按類型分類的市場吸引力分析
- 按產品分類的市場吸引力分析
- 按技術分類的市場吸引力分析
- 途徑進行的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球細胞訊號市場分析：按類型

按類型概述
按類型分類的歷史和預測資料分析
內分泌訊號傳導
旁分泌訊號傳導
自分泌訊號
其他

第 6 章：全球細胞訊號市場分析：按產品

概述（按產品）
按產品分類的歷史和預測資料分析
耗材
儀器儀表

第 7 章：全球細胞訊號市場分析：依技術分類

依技術概述
按技術進行歷史和預測數據分析
流式細胞儀
顯微鏡檢查
蛋白質印跡法
酵素連結免疫吸附試驗
其他

第 8 章：全球細胞訊號市場分析：按途徑

依途徑概述
依途徑進行歷史和預測資料分析
AKT 訊號通路
Ampk 訊號通路
ErbB/HER 訊息通路
其他訊號通路

第 9 章：全球細胞訊號市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：細胞訊號公司的競爭格局

細胞訊號市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Qiagen

公司概況
公司收入
產品
最新動態

Becton

公司概況
公司收入
產品
最新動態

Dickinson And Company

公司概況
公司收入
產品
最新動態

Bio-Rad Laboratories Inc.

公司概況
公司收入
產品
最新動態

Bio-Techne Corporation

公司概況
公司收入
產品
最新動態

Cell Signaling Technology Inc.

公司概況
公司收入
產品
最新動態

Danaher

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

PerkinElmer Inc.

公司概況
公司收入
產品
最新動態

Promega Corporation

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11214388

The global demand for Cell Signaling Market is presumed to reach the market size of nearly USD 11.76 Billion by 2032 from USD 5.84 Billion in 2023 with a CAGR of 8.08% under the study period 2024-2032.

Cell signaling is a complex and essential biological process through which cells communicate with one another to regulate various physiological functions and maintain homeostasis. This intricate system involves the transmission of signals from one cell to another via signaling molecules, such as hormones, neurotransmitters, and cytokines. These molecules bind to specific receptors on the target cell's surface or within its interior, initiating a cascade of intracellular events that ultimately lead to a cellular response. The process can be broadly categorized into several types, including autocrine, paracrine, endocrine, and juxtacrine signaling, each characterized by the distance over which signals travel and their impact on target cells. Effective cell signaling is crucial for numerous biological processes, including growth, immune responses, and tissue repair. Disruptions in signaling pathways are often implicated in various diseases, highlighting the importance of understanding and manipulating these pathways for therapeutic interventions.

MARKET DYNAMICS

The cell signaling market is experiencing robust growth attributed to the increasing prevalence of chronic diseases and cancer, underscoring the need for advanced therapeutic strategies and diagnostic tools. As researchers delve deeper into these conditions' molecular mechanisms, the demand for sophisticated cell signaling assays and reagents has surged. Additionally, the rapid advancement of biotechnology and genomics has facilitated the development of these signaling technologies, offering new opportunities for market expansion. The integration of high-throughput screening methods and personalized medicine further propels market growth by enabling more precise and tailored therapeutic approaches. Moreover, pharmaceutical and biotechnology companies' rising investments in research and development are driving innovation and accelerating the development of new products. The growing awareness of the significance of cellular communication in disease progression and treatment also contributes to the expanding market. Furthermore, strategic collaborations between academic institutions and industry players foster innovation and drive market opportunities. However, regulatory complexities and high costs associated with advanced cell signaling technologies can hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cell Signaling. The growth and trends of Cell Signaling industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cell Signaling market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Endocrine Signaling
Paracrine Signaling
Autocrine Signaling
Others

By Product

Consumables
Instruments

By Technology

Flow Cytometry
Microscopy
Western Blotting
ELISA
Others

By Pathway

AKT Signaling Pathway
Ampk Signaling Pathway
ErbB/HER Signaling Pathway
Other Signaling Pathway

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell Signaling market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Signaling market include Thermo Fisher Scientific Inc., Qiagen, Becton, Dickinson And Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., Danaher, Merck KGaA, PerkinElmer Inc., Promega Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CELL SIGNALING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Technology
- 3.7.4 Market Attractiveness Analysis By Pathway
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CELL SIGNALING MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Endocrine Signaling Historic and Forecast Sales By Regions
5.4. Paracrine Signaling Historic and Forecast Sales By Regions
5.5. Autocrine Signaling Historic and Forecast Sales By Regions
5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL CELL SIGNALING MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data Analysis By Product
6.3. Consumables Historic and Forecast Sales By Regions
6.4. Instruments Historic and Forecast Sales By Regions

7. GLOBAL CELL SIGNALING MARKET ANALYSIS BY TECHNOLOGY

7.1. Overview By Technology
7.2. Historical and Forecast Data Analysis By Technology
7.3. Flow Cytometry Historic and Forecast Sales By Regions
7.4. Microscopy Historic and Forecast Sales By Regions
7.5. Western Blotting Historic and Forecast Sales By Regions
7.6. ELISA Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL CELL SIGNALING MARKET ANALYSIS BY PATHWAY

8.1. Overview By Pathway
8.2. Historical and Forecast Data Analysis By Pathway
8.3. AKT Signaling Pathway Historic and Forecast Sales By Regions
8.4. Ampk Signaling Pathway Historic and Forecast Sales By Regions
8.5. ErbB/HER Signaling Pathway Historic and Forecast Sales By Regions
8.6. Other Signaling Pathway Historic and Forecast Sales By Regions

9. GLOBAL CELL SIGNALING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CELL SIGNALING COMPANIES

10.1. Cell Signaling Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CELL SIGNALING INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Thermo Fisher Scientific Inc.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Qiagen
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Becton
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Dickinson And Company
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Bio-Rad Laboratories Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Bio-Techne Corporation
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Cell Signaling Technology Inc.
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Danaher
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Merck KGaA
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. PerkinElmer Inc.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Promega Corporation
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments